Insider Transactions in Q1 2022 at Privia Health Group, Inc. (PRVA)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 28
2022
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-17.04%
|
$500,000
$25.09 P/Share
|
Mar 28
2022
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.56%
|
$40,000
$2.0 P/Share
|
Mar 28
2022
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
10,000
-26.74%
|
$250,000
$25.09 P/Share
|
Mar 28
2022
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.1%
|
$20,000
$2.0 P/Share
|
Feb 22
2022
|
Thomas Bartrum |
SELL
Open market or private sale
|
Direct |
10,000
-26.74%
|
$250,000
$25.32 P/Share
|
Feb 22
2022
|
Thomas Bartrum |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.1%
|
$20,000
$2.0 P/Share
|
Feb 22
2022
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-17.04%
|
$500,000
$25.3 P/Share
|
Feb 22
2022
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.56%
|
$40,000
$2.0 P/Share
|
Feb 10
2022
|
Parth Mehrotra Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,288
-2.58%
|
$132,200
$25.02 P/Share
|
Feb 10
2022
|
Parth Mehrotra Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,288
+4.9%
|
$10,576
$2.0 P/Share
|
Jan 05
2022
|
David Mountcastle EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,391
-36.93%
|
$409,775
$25.53 P/Share
|
Jan 05
2022
|
David Mountcastle EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,554
+32.69%
|
$43,108
$2.0 P/Share
|
Jan 05
2022
|
Jeffrey Scott Sherman EVP, CFO and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
61,307
+50.0%
|
-
|